1
|
Deheuninck J and Luo K: Ski and SnoN,
potent negative regulators of TGF-beta signaling. Cell Res.
19:47–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jahchan NS and Luo K: SnoN in mammalian
development, function and diseases. Curr Opin Pharmacol.
10:670–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Bonni S and Bonni A: SnoN signaling in
proliferating cells and postmitotic neurons. FEBS Lett.
586:1977–1983. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Stroschein SL, Wang W, Zhou S, et al:
Negative feedback regulation of TGF-β signaling by the SnoN
oncoprotein. Science. 286:771–774. 1999.
|
5
|
Pan D, Zhu Q, Conboy MJ, Conboy IM and Luo
K: SnoN activates p53 directly to regulate aging and tumorigenesis.
Aging Cell. 11:902–911. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Javelaud D, van Kempen L, Alexaki VI, et
al: Efficient TGF-β/SMAD signaling in human melanoma cells
associated with high c-SKI/SnoN expression. Mol Cancer. 10:2–14.
2011.
|
7
|
Pan D, Zhu Q and Luo K: SnoN functions as
a tumour suppressor by inducing premature senescence. EMBO J.
28:3500–3513. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tecalco-Cruz AC, Sosa-Garrocho M,
Vázquez-Victorio G, et al: Transforming growth factorβ-/SMAD target
gene SKIL is negatively regulated by the transcriptional cofactor
complex SnoN-Smad4. J Biol Chem. 287:26764–26776. 2012.
|
9
|
Krakowski AR, Laboureau J, Mauviel A, et
al: Cytoplasmic SnoN in normal tissues and nonmalignant cells
antagonizes TGF-beta signaling by sequestration of the Smad
proteins. Proc Natl Acad Sci USA. 102:12437–12442. 2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhu Q, Krakowski AR, Dunham EE, et al:
Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol.
27:324–339. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bravou V, Antonacopoulou A, Papadaki H, et
al: TGF-beta repressors SnoN and Ski are implicated in human
colorectal carcinogenesis. Cell Oncol. 31:41–51. 2009.PubMed/NCBI
|
12
|
Shinagawa T, Dong HD, Xu M, Maekawa T and
Ishii S: The sno gene, which encodes a component of the histone
deacetylase complex, acts as a tumor suppressor in mice. EMBO J.
19:2280–2291. 2000. View Article : Google Scholar : PubMed/NCBI
|
13
|
Jahchan NS, Wang D, Bissell MJ and Luo K:
SnoN regulates mammary gland alveologenesis and onset of lactation
by promoting prolactin/Stat5 signaling. Development. 139:3147–3156.
2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
Jahchan NS, You YH, Muller WJ and Luo K:
Transforming growth factor-beta regulator SnoN modulates mammary
gland branching morphogenesis, postlactational involution, and
mammary tumorigenesis. Cancer Res. 70:4204–4213. 2010. View Article : Google Scholar
|
15
|
Akagi I, Miyashita M, Makino H, et al:
SnoN overexpression is predictive of poor survival in patients with
esophageal squamous cell carcinoma. Ann Surg Oncol. 15:2965–2975.
2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Chang K, Marran K, Valentine A and Hannon
GJ: RNAi in cultured mammalian cells using synthetic siRNAs. Cold
Spring Harb Protoc. 2012:956–961. 2012. View Article : Google Scholar
|
17
|
Hannon GJ: RNA interference. Nature.
418:244–251. 2002. View
Article : Google Scholar : PubMed/NCBI
|
18
|
Conde J, Ambrosone A, Sanz V, et al:
Design of multifunctional gold nanoparticles for in vitro
and in vivo gene silencing. ACS Nano. 6:8316–8324. 2012.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Band AM and Laiho M: SnoN oncoprotein
enhances estrogen receptor-α transcriptional activity. Cell Signal.
24:922–930. 2012.PubMed/NCBI
|